Company Overview
High Tide Inc. engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Bricks and Mortar, E-commerce, and Medical Cannabis Distribution segments. It manufactures and distributes consumption accessories; cannabis; and hemp derived products. The company also engages in data analytics; advertising; product sourcing and imports; event-based cannabis retail; medical cannabis distribution; accessories retail; and other related services. It provides its products under the Daily High Club, DankStop, FAB CBD, GC, Nuleaf Naturals, Smoke Cartel, Blessed CBD, Fastendr, Famous Brandz, Queen of Bud, Canna Cabana, Grasscity, Daily High Club, and Valiant Distribution brands. The company sells its products through a network of retail stores, e-commerce platforms, and the wholesale distribution arm. The company was formerly known as High Tide Ventures Inc. and changed its name to High Tide Inc. in October 2018. The company was founded in 2009 and is headquartered in Calgary, Canada.
Why Investors Should Care
Revenue has grown at a 18.5% CAGR over the past five years.
Recent Developments
- Oct 2025 Revenue of $593.99M (+13.7% YoY); net profit $-50.75M.
- Trailing 12 Months Year-on-year growth — revenue +32.8%, earnings +1531.8%.
- 5-Year Trend Long-term compounding — revenue CAGR 18.5%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 18.51% |
| 1 Year: | 32.80% |
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | 1,531.80% |
Stock Price Performance
| 1 Year: | +9.35% |
| 6 Months: | +10.25% |
| 3 Months: | +15.95% |
| 1 Month: | +16.96% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)73.81 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Compounding revenue at 18.5% over 5 years.
CONS
- Trading 32.4% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Healthcare).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | HITI High Tide Inc. PHARMA | 2.69 | -6.90 | $239.79M | 0.00% | 6.20% | -26.04% | 18.51% | - |
| 2 | LLY Eli Lilly and Company SPXR3KPHARMA | 1,123.91 | 37.80 | $1.00T | 0.60% | - | 102.29% | 7.20% | 11.41% |
| 3 | JNJ Johnson & Johnson SPXR3KPHARMA | 269.12 | 31.22 | $648.55B | 1.98% | 14.88% | 25.74% | 2.43% | 4.76% |
| 4 | ABBV AbbVie Inc. SPXR3KPHARMA | 248.78 | 70.48 | $439.62B | 2.78% | 10.47% | -129.24% | 1.75% | -29.06% |
| 5 | MRK Merck & Co., Inc. SPXR3KPHARMA | 148.46 | 118.77 | $366.28B | 2.31% | - | 6.96% | 5.64% | 10.01% |
| 6 | UNH UnitedHealth Group Incorporated SPXR3KPHARMA | 400.84 | 25.74 | $359.79B | 2.47% | 9.74% | 14.15% | 10.40% | 5.43% |
| 7 | NVS Novartis AG PHARMA | 137.70 | 20.80 | $261.73B | 3.36% | 21.09% | 30.35% | 9.25% | 26.22% |
| 8 | AZN AstraZeneca PLC NDXPHARMA | 160.04 | 23.99 | $248.20B | 2.00% | 15.97% | 21.96% | 9.82% | 45.96% |
| 9 | TMO Thermo Fisher Scientific Inc. SPXR3KPHARMA | 603.02 | 32.49 | $222.97B | 0.29% | 8.14% | 13.51% | 8.81% | 12.95% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jan 2025 | Apr 2025 | Jul 2025 | Oct 2025 | Jan 2026 | Apr 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 137.80M | 149.69M | 164.03M | 178.33M | 179.30M |
| Cost of Revenue | - | 102.33M | 109.60M | 121.50M | 133.92M | 130.91M |
| Gross Profit | - | 35.47M | 40.09M | 42.53M | 44.41M | 48.39M |
| Operating Expenses | - | 33.09M | 34.71M | 36.40M | 40.27M | 40.29M |
| Operating Income | - | 2.38M | 5.38M | 6.12M | 4.13M | 8.10M |
| EBITDA | - | 6.32M | 10.32M | -37.16M | 12.63M | 11.50M |
| Interest Expense | - | 3.23M | 3.34M | 3.23M | 4.92M | 5.03M |
| Pretax Income | - | -2.79M | 901.00K | -46.89M | -312.00K | 319.00K |
| Tax Provision | - | 46.00K | 69.00K | -178.00K | 40.00K | 295.00K |
| Net Income | - | -2.90M | 598.00K | -45.64M | 1.21M | -197.00K |
| Diluted EPS | -0.03 | -0.04 | 0.01 | - | 0.01 | 0.00 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Revenue | - | 356.85M | 487.67M | 522.31M | 593.99M |
| Cost of Revenue | - | 255.90M | 356.36M | 379.80M | 440.46M |
| Gross Profit | - | 100.95M | 131.31M | 142.50M | 153.53M |
| Operating Expenses | - | 121.06M | 133.97M | 127.19M | 138.09M |
| Operating Income | - | -20.11M | -2.66M | 15.32M | 15.44M |
| EBITDA | - | -33.65M | -4.20M | 33.78M | -13.74M |
| Interest Expense | - | 9.95M | 11.63M | 12.79M | 13.38M |
| Pretax Income | - | -73.76M | -48.60M | -4.40M | -51.43M |
| Tax Provision | - | -2.92M | -7.64M | -593.00K | -25.00K |
| Net Income | - | -71.76M | -39.31M | -4.34M | -50.75M |
| Diluted EPS | - | -1.14 | -0.53 | -0.05 | -0.62 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 274.74M | 233.40M | 246.21M | 349.06M |
| Current Assets | - | 64.06M | 68.64M | 85.79M | 136.88M |
| Cash & Equivalents | - | 25.08M | 30.12M | 47.27M | 47.88M |
| Inventory | - | 23.41M | 25.97M | 29.34M | 67.41M |
| Receivables | - | 7.92M | 7.57M | 3.31M | 5.62M |
| Total Liabilities | - | 112.71M | 99.73M | 100.70M | 246.28M |
| Current Liabilities | - | 59.94M | 58.14M | 61.48M | 99.92M |
| Long Term Debt | - | 17.03M | 12.51M | 7.54M | 81.39M |
| Total Debt | - | 69.88M | 72.53M | 74.61M | 148.92M |
| Total Equity | - | 156.35M | 131.56M | 143.27M | 87.61M |
| Shares Outstanding | - | 71.02M | 75.30M | 80.79M | 87.48M |
Cash Flows (Annual)
Figures in USD.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 4.50M | 20.66M | 35.55M | 23.87M |
| Investing Cash Flow | - | -8.59M | -5.72M | -11.01M | -22.29M |
| Financing Cash Flow | - | 15.17M | -9.26M | -7.72M | 202.00K |
| Capital Expenditure | - | -9.05M | -6.08M | -9.75M | -10.65M |
| Free Cash Flow | - | -4.56M | 14.58M | 25.80M | 13.22M |
| Net Change in Cash | - | 11.07M | 5.68M | 16.81M | 1.78M |
Ratios (Annual)
Figures in %.
| Metric | Oct 2021 | Oct 2022 | Oct 2023 | Oct 2024 | Oct 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 28.3% | 26.9% | 27.3% | 25.8% |
| Operating Margin % | - | -5.6% | -0.5% | 2.9% | 2.6% |
| Net Margin % | - | -20.1% | -8.1% | -0.8% | -8.5% |
| ROE % | - | -45.9% | -29.9% | -3.0% | -57.9% |
| ROCE % | - | -9.4% | -1.5% | 8.3% | 6.2% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Tidal Investments LLC | 1.87% | 1.66M | $4.29M |
| 2 | AdvisorShares Investments, LLC | 1.33% | 1.18M | $3.05M |
| 3 | Renaissance Technologies, LLC | 1.01% | 899.93K | $2.32M |
| 4 | Two Sigma Investments, LP | 0.74% | 654.93K | $1.69M |
| 5 | Federation Des Caisses Desjardins Du Quebec | 0.29% | 260.11K | $671.07K |
| 6 | Baader Bank Aktiengesellschaft | 0.28% | 250.00K | $645.00K |
| 7 | Millennium Management Llc | 0.28% | 249.47K | $643.62K |
| 8 | Ewing Morris & Co. Investment Partners Ltd. | 0.27% | 240.00K | $619.20K |
| 9 | Point72 Asset Management, L.P. | 0.22% | 196.96K | $508.16K |
| 10 | Jane Street Group, LLC | 0.12% | 109.71K | $283.05K |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for HITI
Is High Tide Inc. (HITI) Stock Turning Into a Cannabis Growth Story After Record Quarterly Results? - finance.yahoo.com
<a href="https://news.google.com/rss/articles/CBMikwFBVV95cUxPeVBGNjltTTVfLVByS2lwVFdXeEJJTTYzc0FBMFpoVnh6V2Nhd0RSLVRhWEhwRjc5MmtrSkVZd2tZanYzS2NHVldfNnJ4VUNNUTFrd3lFUUtfR211NjJCTXRRVVc1YmxycTlWcEZPdkE3YjgzX2hmeURpdUlWZ1IzZWM3OFVOM0NoWWFvdT…
High Tide (HITI) to Announce Earnings on Monday - marketbeat.com
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxNS1ZpX2Zva3RJOE80YmZLZ0RjNGdiTjA4YnFSQ3JtaE4yaWlRemN5dGNlWUlmSEw0SnRSaEtEajlYZVY2OFJ2VDUwelhCTjFPZ2U3eHlLcDNHV081THV3bTQxTjBCR05HeEdGQUZIZXo1OXZobXJxMkJJajZ2a2Nxb0pkRzR4TlBFd0VVRU…
High Tide: German Expansion Just Added Another Bullish Catalyst (NASDAQ:HITI) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxONGxrTWNsd2ZsNm5qZmhJTU51eFZWamk3STBuMUZvVWZqUnl3eXFLSE45R1RsckJLOGtseUg1X2k0TkZ4OG1lQnJoalJneVhESTAxYzR2dF95OVdacUJOTkFmN3NHak8tUmZyLVhVR3JCeEFsNzdvRkZYUk5kcVZRZWtKU2FWUnNmbXFpN1…
HITI - High Tide Inc Stock Price and Quote - Finviz
<a href="https://news.google.com/rss/articles/CBMiRkFVX3lxTE9RSkRoblFYRDRmNXpOMEZsODNzWlFFMUl2aEJ1X2VJUG9UakpSczJuaW5Zc2UyTEpOcnMxU3lTRmRDTDZVQkE?oc=5" target="_blank">HITI - High Tide Inc Stock Price and Quote</a> <font color="#…
High Tide Shareholders Approve Five-Member Board, Rights Plan - Stock Titan
<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPalJ4dDNuaWVKcEJWSmlEZGlWaWgtSFdfNmVHV2ZOYVQ1OW51NnV0Tnl2SklxVHJLNkF4cUNCNUotSmNuWkNDUUd6YTVsaHNJeFVBYmxpcGxLNGd1VUp2RXUzTVpmLTczMEtxMXphcVNMVlkxVldHdWNWd3g0bDh3aS0zbTd4RkMzNzZUd2…
High Tide Inc. (HITI) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxOc3dPaUpkUUYwRkstcm9NOGRZQ0VCTW9IVHZoZml1TFBNY0FYbVVDdi0tMTU3S0ZDM3YyTlBKcUNFZXhMV1B6c1RlSnpjaGJjSDBMM21wYTVOeV84WEVJQ21ldTZjSE1udnB1OXA0alpKRVRjMVJWLVdXTmRkM255WHRGc2hIekE4YjgtMG…
HITI — Frequently Asked Questions
What is the current share price of High Tide Inc. (HITI)?
As of 2026-09-19 21:16 PDT, High Tide Inc. (HITI) trades at $2.69 on NasdaqCM. Its 52-week range is $2.05 to $3.98.
What is the market capitalisation of HITI?
High Tide Inc. (HITI) has a market capitalisation of $239.79M on NasdaqCM.
What is the P/E ratio of HITI?
HITI trades at a trailing price-to-earnings (P/E) ratio of -6.90. The industry average P/E is 24.83. Its price-to-book (P/B) ratio is 3.55.
What is the return on equity (ROE) of HITI?
HITI has a return on equity (ROE) of -26.04%. Its return on capital employed (ROCE) is 6.20%.
Is HITI a good stock to buy?
This page provides a data-driven analysis of High Tide Inc. (HITI), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.